Steve Schonfeld’s NRX Pharmaceuticals NRXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.2K Buy
+14,801
New +$52.6K ﹤0.01% 2573
2026
Q2
– Sell
-19,876
Closed -$42.3K – 2877
2026
Q1
$42.3K Buy
+19,876
New +$40.1K ﹤0.01% 1991
2022
Q1
– Sell
-2,810
Closed -$135K – 2809
2021
Q4
$135K Buy
+2,810
New +$203K ﹤0.01% 1836

Other funds holding NRXP

Steve Schonfeld's NRXP Position: Q3 2026 in Review

Steve Schonfeld opened a new position in NRX Pharmaceuticals (NRXP) in Q3 2026: 14,801 shares worth $43.2K. The stake represents ﹤0.01% of the portfolio and ranks #2573 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in NRXP as recently as Q1 2026.

Steve Schonfeld first reported a position in NRXP in Q4 2021 and has held it in 3 quarters since. The position peaked at $135K in Q4 2021. 50 funds tracked by Wall St. Rank hold NRXP as of Q3 2026.

  • Steve Schonfeld held 14,801 shares of NRX Pharmaceuticals worth $43.2K as of Q3 2026.
  • NRX Pharmaceuticals was a new Steve Schonfeld position in Q3 2026.
  • NRX Pharmaceuticals made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #2573 holding.
  • Steve Schonfeld first reported a position in NRX Pharmaceuticals in Q4 2021 and has held it in 3 quarters since.
  • Steve Schonfeld's NRX Pharmaceuticals position peaked at $135K in Q4 2021.
  • 50 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.